Snapshot from Aug 02, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Relmada Q2 2026 earnings call
Business earnings call

Relmada Q2 2026 earnings call

Analysis based on 6 articles · First reported Jul 16, 2026 · Last updated Jul 16, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is a routine earnings call notice with minimal market impact. Investors may watch for updates on clinical progress and financial health.

Biotechnology
Event Summary

Relmada Therapeutics, Inc. (Nasdaq: RLMD) announced plans to host a conference call and webcast on August 6, 2026, to discuss financial results for the second quarter ended June 30, 2026, and recent business progress. The company is a clinical-stage biotechnology firm developing therapies for oncology and central nervous system disorders, with lead candidates NDV-01 and sepranolone in mid-stage development.

Key Actions
10 Relmada Therapeutics announced conference call
Entities Involved
stock
Relmada Therapeutics
Relmada is the subject of the event, announcing its Q2 2026 earnings call. The event provides a platform to update investors on financials and clinical progress.
Importance 100.0 Sentiment 0.0
exch
Nasdaq
Nasdaq is the exchange where Relmada is listed (ticker RLMD). The event has no direct impact on Nasdaq.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.